Shmulik Hess
Chief Operating Officer bei MEDIWOUND LTD.
Profil
Dr. Shmulik Hess is a Chief Operating & Commercial Officer at MediWound Ltd.
Dr. Hess was previously employed as a Chief Executive Officer by Valin Technologies Ltd., a Global Operations by SciGen Ltd., a Chief Executive Officer by Active PX Ltd., a Chief Executive Officer by Enlivex Therapeutics Ltd., and a Chief Executive Officer by Tabby Therapeutics Ltd.
He received his doctorate degree from The Hebrew University of Jerusalem.
Aktive Positionen von Shmulik Hess
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIWOUND LTD. | Chief Operating Officer | 01.12.2023 |
Ehemalige bekannte Positionen von Shmulik Hess
| Unternehmen | Position | Ende |
|---|---|---|
| Valin Technologies Ltd. | Chief Executive Officer | 01.11.2018 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Chief Executive Officer | 01.09.2011 |
| SCIGEN LIMITED | Chief Operating Officer | 01.03.2010 |
| ENLIVEX THERAPEUTICS LTD. | Chief Executive Officer | - |
Tabby Therapeutics Ltd.
 Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Chief Executive Officer | - |
Ausbildung von Shmulik Hess
| The Hebrew University of Jerusalem | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDIWOUND LTD. | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Valin Technologies Ltd. | |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Health Technology |
